تجمع الرعاية التنفسية respiratory care

🫁 When Oxygen Becomes a Drug With a Dose Oxygen saves lives—but more is not always better. For decades, oxygen was treated as a harmless therapy that could be administered generously. Modern respiratory physiology tells a more precise story: oxygen is a powerful drug, and excessive exposure can cause harm. High oxygen concentrations may increase the formation of reactive oxygen species, promote oxidative stress, worsen absorption atelectasis, impair mucociliary function, and alter pulmonary vascular tone. In vulnerable patients, prolonged hyperoxia may contribute to alveolar injury and delayed recovery. There is also a hidden physiological problem: a patient may show a beautiful oxygen saturation while receiving far more oxygen than necessary. The number looks reassuring, but the treatment may be producing an avoidable biological burden. The goal of oxygen therapy is therefore not to achieve the highest possible saturation. It is to achieve an appropriate target range for the clinical context, using the lowest effective inspired oxygen concentration and reassessing the patient continuously. This is especially important in patients at risk of hypercapnic respiratory failure, where excessive oxygen can worsen carbon-dioxide retention through several mechanisms, including altered ventilation–perfusion matching and the Haldane effect. The Expert Takeaway Oxygen is not simply a comfort measure or a “more is better” therapy. It is a titratable pharmacological intervention with benefits, side effects, and a therapeutic range. The critical question is not: “Can we give more oxygen?” It is: “What oxygen dose does this patient actually need—and when should we reduce it?” Discussion: Should oxygen prescriptions include a target saturation, flow rate, and reassessment plan just like any other medication?